Fundraising Fox

Sue Siegel

Investor

Obvious Champion at Obvious Ventures

About

Sue Siegel has worked as a CEO, venture capitalist, and board member across private, public, and non-profit organizations. She previously served as GE's Chief Innovation Officer, CEO of GE Ventures & Licensing, and CEO of Healthymagination, and earlier was a General Partner at Mohr Davidow Ventures focused on Life Sciences & Health. She also led Affymetrix, a genomics company, from a pre-revenue startup to a publicly listed company, and is a Senior Lecturer at MIT's Sloan School of Management.

Invests in

BiotechDigital HealthHealthtechMedical Devices

Investments

Board seats

Align TechnologiesIlluminaNevro

Per the firm's website.

Colleagues at Obvious Ventures

Frequently asked questions

Who is Sue Siegel?
Sue Siegel has worked as a CEO, venture capitalist, and board member across private, public, and non-profit organizations. She previously served as GE's Chief Innovation Officer, CEO of GE Ventures & Licensing, and CEO of Healthymagination, and earlier was a General Partner at Mohr Davidow Ventures focused on Life Sciences & Health. She also led Affymetrix, a genomics company, from a pre-revenue startup to a publicly listed company, and is a Senior Lecturer at MIT's Sloan School of Management.
Where does Sue Siegel work?
Sue Siegel is Obvious Champion at Obvious Ventures.
What does Sue Siegel invest in?
Sue Siegel invests in Biotech, Digital Health, Healthtech, Medical Devices.
What boards does Sue Siegel sit on?
Sue Siegel holds tracked board seats at Align Technologies, Illumina, Nevro.